August 8, 2017 / 9:07 PM / 5 months ago

BRIEF-Protagonist Therapeutics reports Q2 loss per share of $0.89

Aug 8 (Reuters) - Protagonist Therapeutics Inc

* Protagonist therapeutics reports second quarter 2017 financial results and business highlights

* Protagonist therapeutics inc - qtrly ‍net loss per share attributable to common stockholders, basic and diluted $ 0.89

* Q2 earnings per share view $-0.86 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below